According to a Billboard report Tuesday morning, Live Nation Inc. (NYSE: LYV) "has entered into a long-term global partnership" with Canadian rock band Nickelback, following other high profile acts U2, Madonna, and Jay-Z. The reported $50-$70 million deal is set to commence after the band finishes its current deal with Road Runner Records, a record label in the Warner Music Group Corp. (NYSE: WMG), and will include three tours and albums with the possibility of a fourth left open. Virtually every aspect of the band's career will be managed and distributed via Live Nation, and the band will begin touring in Live Nation venues as soon as next year.
Reuters further reports that the band has two albums and a greatest hits album left with Road Runner Records, with the band's last album selling 10 million copies. The news source speculates that the deal could be expensive if the band's new albums in the future fail to deliver the success that the band has enjoyed to date. The deal also throws into question the value of Road Runner Records after Warner Music Group bought the label in December 2006 for $73.5 million. Despite other high profile artists, Nickelback is the label's most successful act.
Live Nation has raised the stakes for music companies since beginning to sign major artists last year. By offering services for nearly every aspect of those acts' careers, Live Nation means managing careers are simplified in theory. In addition, the growth of the digital music market has made it easier for the company and the acts it signs to distance the services from the tendencies associated with music companies and traditional recordings deals. Unfortunately, since the deals have yet to commence for any artist, the success of deals such as this have yet to be seen.
Last updated: February 13, 2012: 04:55 PM
Hot Stocks
DailyFinance Headlines
- 5 Things to Watch This Week: Cars, Games, Hearts, and a Lot of Z's
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
Benzinga Headlines
- Military Budget Cuts Hit These Contractors
- Earnings Preview: Tesla Hoping to Retain its Drive
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
TheFlyOnTheWall.com Headlines
- Ultra Clean sees Q1 EPS 15c-18c vs. consensus 9c
- Health Management reports Q4 same hospital revenue up 5% to $1.42M
- Ultra Clean Q4 EPS included a 28c tax benefit
- Ultra Clean reports Q4 EPS 34c vs. consensus 3c
- Health Management reports Q4 EPS 26c vs. consensus 20c
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 5 Things to Watch This Week: Cars, Games, Hearts, and a Lot of Z's
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
Suddenly, Amazon Doesn't Love Its Moms Anymore

